Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Belle Health vs Oak

Belle Health and Oak both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
Belle Health logo

Belle Health

8.3
★★★★☆4.2/5

Best for: semaglutide at $119/month, 37% below the typical price

Visit Belle Health →
VS
Oak logo

Oak

7.8
★★★★☆3.9/5

Best for: semaglutide at $119/month, 37% below the typical price

Visit Oak →

If you are choosing between Belle Health and Oak, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Belle Health leads our six-part score, 8.3 to 7.8. One of the two has an FDA warning letter on record, covered below.

Belle Health vs Oak price

Belle Health and Oak start at the same figure, $119 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide costs the same at both, $119 a month; tirzepatide is cheaper at Oak ($185 a month vs $199 a month on a prepaid plan).

Medications and formats

Both sell semaglutide and tirzepatide.

On format they match: each offers compounded injections.

Where each one treats patients

Belle Health lists 50 states, and Oak does not publish where it ships.

Pricing

Belle Health

Flat-rate (all doses)Compounded
$119/mo
semaglutide
Flat-rate (all doses, 3-month bundle)Compounded
$199/mo
tirzepatide

Oak

Starting (flat across all dosages)Compounded
$119/mo
semaglutide

Semaglutide from $119/mo. A '$200 off' new-patient offer is advertised, but its terms and resulting price are not published. Other Oak pages show $133, $167 and $190; $119 is the headline price.

Starting (flat across all dosages)Compounded
$185/mo
tirzepatide

Tirzepatide from $185/mo, with 'One price · All dosages · No subscriptions.' A $200-off new-patient offer is advertised, but how it applies and the final price are not published before the intake questionnaire.

What each price covers

Both prices cover the medication itself, shipping and coaching.

Belle Health's price also covers the clinician visit, which Oak does not claim.

Belle Health is silent on lab work.

Oak is silent on the clinician visit and lab work.

Belle Health

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

In the price

Oak

Covered by the monthly price

Medication

In the price

Clinician visits

Not stated

Shipping

In the price

Lab work

Not stated

Coaching

In the price

Where each one scores higher

Overall, Belle Health scores 8.3 and Oak 7.8 out of 10.

Belle Health is stronger on accessibility (10.0 vs 5.0) and support (8.5 vs 6.0).

Oak is stronger on trust & safety (6.5 vs 4.5).

Value, effectiveness and user experience are within half a point.

How we score

Belle Health

8.3/10

Overall

Oak

7.8/10

Value25%

8.2A
vs
B
8.2

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

4.5A
vs
B
6.5

Accessibility10%

10.0A
vs
B
5.0

Support10%

8.5A
vs
B
6.0

FDA warning letters

Belle Health has an FDA warning letter on record.

Oak has no FDA warning letter on record with us.

Features & Coverage

FeatureBelle HealthOak
Starting Price$119/mo$119/mo
Features✓6 features4 features
States Available50Not disclosed
Compounded✓ Yes✓ Yes
Brand Name——
FSA/HSA Accepted——
FDA Warning Letters1 letter✓None

About Belle Health

Belle Health sells compounded semaglutide at $119/month and compounded tirzepatide at $199/month, both on a 3-month bundle. Pricing is flat: the monthly cost is the same at every dose, with no escalation surcharge as you titrate up. The platform is national and direct-to-consumer, includes free weekly registered-dietitian sessions, and names its compounding pharmacy partners openly.

Read our full Belle Health review →

About Oak

Oak sells compounded semaglutide and tirzepatide through telehealth. Oak Longevity Holdings Corp. operates the business, and prescriptions are issued through NVP Medical Group, P.A.

Read our full Oak review →

Pros & Cons

Belle Health

What we like

  • Semaglutide costs $119 a month, 36% below the $185 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $199 a month, 20% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits, shipping and coaching
  • Serves all 50 states

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued Belle Health a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Oak

What we like

  • Semaglutide costs $119 a month, 36% below the $185 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $185 a month, 26% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, shipping and coaching
  • We found no FDA warning letters issued to Oak

Watch-outs

  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Oak

Oak is where we would start, above all for semaglutide at $119/month, 37% below the typical price. Belle Health fits better if semaglutide at $119/month, 37% below the typical price is your priority.

Choose Belle Health if…

You want semaglutide at $119/month, 37% below the typical price and an opening price near $119 a month.

Choose Oak if…

You want semaglutide at $119/month, 37% below the typical price and an opening price near $119 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.7

Eden

Coverage in all 50 states, which most sellers will not confirm

8.3

SnagRx

Semaglutide at $99/month, 48% below the typical price

9.3

Embody

Knowing which pharmacy fills the vial: it names RedRock Pharmacy

Belle Health vs Oak: FAQ

Neither on the entry price: Belle Health and Oak both start at about $119 a month. The difference is in what the price includes.
Yes, both sell semaglutide and tirzepatide.
Belle Health lists 50 states; Oak does not publish where it ships. Confirm your state before paying.
Both include the medication itself, shipping and coaching. Only Belle Health includes the clinician visit.
Belle Health has one FDA warning letter on record. Oak has none.
Oak pays us a commission on sign-ups through our links; Belle Health does not. Scores are computed the same way for both.

Or see the full category ranking.